Total ganglioside ablation at mouse motor nerve terminals alters neurotransmitter release level

Synapse

Volumn 64, Issue 4, 2010, Pages 335-338

  Zitman, Femke M P ^a   Todorov, Boyan ^a   Furukawa, Keiko ^b   Furukawa, Koichi ^b   Willison, Hugh J ^c   Plomp, Jaap J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Ganglioside; GM3; Knockout mouse; Neuraminidase; Neuromuscular junction; Neurotransmitter release; Sialic acid; Synaptic transmission

Indexed keywords

GANGLIOSIDE GD2; GANGLIOSIDE GD3; GANGLIOSIDE GM2; SIALIDASE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; IN VITRO STUDY; MALE; MOUSE; NERVE ENDING; NERVE STIMULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCHOLINE; ANIMALS; CALCIUM; ELECTRIC STIMULATION; GANGLIOSIDES; MICE; MICE, KNOCKOUT; NEURAMINIDASE; NEUROMUSCULAR JUNCTION; SYNAPTIC POTENTIALS;

EID: 73449117896     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20747     Document Type: Article

References (16)

1. Bullens RW, O'Hanlon GM, Wagner E, Molenaar PC, Furukawa K, Furukawa K, Plomp JJ, Willison HJ. 2002. Complex gangliosides at the neuromuscular junction are membrane receptors for auto-antibodies and botulinum neurotoxin but redundant for normal synaptic function. J Neurosci 22:6876-6884.
2. Inoue M, Fujii Y, Furukawa K, Okada M, Okumura K, Hayakawa T, Furukawa K, Sugiura Y. 2002. Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside. J Biol Chem 277:29881-29888.
3. Isaev D, Isaeva E, Shatskih T, Zhao Q, Smits NC, Shworak NW, Khazipov R, Holmes GL. 2007. Role of extracellular sialic acid in regulation of neuronal and network excitability in the rat hippocampus. J Neurosci 27:11587-11594.
4. Kaja S, van de Ven RC, Broos LA, Veldman H, van Dijk JG, Verschuuren JJ, Frants RR, Ferrari MD, van den Maagdenberg AM, Plomp JJ. 2005. Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness. Neuroscience 135:81-95.
5. Kaja S, van de Ven RC, Broos LA, Frants RR, Ferrari MD, van den Maagdenberg AM, Plomp JJ. 2007. Characterization of acetylcholine release and the compensatory contribution of non-Ca(v)2.1 channels at motor nerve terminals of leaner Ca(v)2.1-mutant mice. Neuroscience 144:1278-1287.
6. Marengo FD, Wang SY, Wang B, Langer GA. 1998. Dependence of cardiac cell Ca2+ permeability on sialic acid-containing sarcolemmal gangliosides. J Mol Cell Cardiol 30:127-137.
7. Nakatani Y, Hotta S, Utsunomiya I, Tanaka K, Hoshi K, Ariga T, Yu RK, Miyatake T, Taguchi K. 2009. Cav2.1 voltage-dependent Ca2+ channel current is inhibited by serum from select patients with Guillain-Barre syndrome. Neurochem Res 34:149-157.
8. Ortiz N, Rosa R, Gallardo E, Illa I, Tomas J, Aubry J, Sabater M, Santafe M. 2001. IgM monoclonal antibody against terminal moiety of GM2. GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neuro-transmitter release. J Neuroimmunol 119:114-123.
9. Perillo MA, Yu RK, Maggio B. 1994. Modulation of the activity of Clostridium perfringens neuraminidase by the molecular organization of gangliosides in monolayers. Biochim Biophys Acta 1193:155-164.
10. Plomp JJ, Willison HJ. 2009. Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol 587:3979-3999.
11. Simpson MA, Cross H, Proukakis C, Priestman DA, Neville DC, Reinkensmeier G, Wang H, Wiznitzer M, Gurtz K, Verganelaki A, Pryde A, Patton MA, Dwek RA, Butters TD, Platt FM, Crosby AH. 2004. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36:1225-1229.
12. Taverna E, Saba E, Rowe J, Francolini M, Clementi F, Rosa P. 2004. Role of lipid microdomains in P/Q-type calcium channel (Cav2.1) clustering and function in presynaptic membranes. J Biol Chem 279:5127-5134.
13. Wood SJ, Slater CR. 2001. Safety factor at the neuromuscular junction. Prog Neurobiol 64:393-429.
14. Yamashita T, Wu YP, Sandhoff R, Werth N, Mizukami H, Ellis JM, Dupree JL, Geyer R, Sandhoff K, Proia RL. 2005. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc Natl Acad Sci USA 102:2725-2730.
15. Zitman FM, Todorov B, Jacobs BC, Verschuuren JJ, Furukawa K, Furukawa K, Willison HJ, Plomp JJ. 2008. Neuromuscular synaptic function in mice lacking major subsets of gangliosides. Neuroscience 156:885-897.
16. Zitman FM, Todorov B, Verschuuren JJ, Jacobs BC, Furukawa K, Furukawa K, Willison HJ, Plomp JJ. 2009. Neuromuscular synaptic transmission in aged ganglioside-deficient mice. Neurobiol Aging doi:10.1016/j.neurobiolaging. 2009.01.007.